December 1st

On Watch for Monday! One can hope for Great News 👍!

Bingo!

STXG with endless shares....lol

#ENZC 2 full weeks of trading left in July and it starts tomorrow! $ENZC https://t.co/vvrDUvzoxu

To burn his trillions of tokens? ????

Bingo!

Definitely just the beginning!

Deferred Revenue - Sale of Distributorship $800,000 https://www.otcmarkets.com/otcapi/company/financial-report/334367/content

AKA Grand Slam!

Bingo! S2 for the Win!

Monoclonal Antibody “Clone 3” is the Cure!
Who then holds the patent for the GP41 “key” on the S2 region of the spike protein? Joseph Cotropia of Bioclonetics Inc. (Now Enzolytics Inc.) holds the patent to GP41 and the monoclonal antibodies that can “irreversibly block” the Glycoprotein GP41 which would stop viral membrane fusion and thus infection. It’s called the Monoclonal Antibody Clone 3 which is the cure for HIV, SARS-CoV-2 and several Cancer.

Why is GP41 important? GP41 is a stable Glycoprotein and unlike GP120 it does not mutate. If one uses GP41 to manufacture “spike proteins” through “Gain-of-Function” experiments you now have a stable site that can be targeted by pharmaceuticals drugs or vaccines! Basically any pathogen that has GP41 can be inactivated and that includes HIV-1, SARS-CoV-2 and other viruses that cause Cancers! Did you think the NWO would release a bioweapon without a built-in back door to turn it off?

Exactly it was just made privet buy the poster was not meant to be public. It was not a sales pitch or investment pitch just very cool to see and hear the DR. that spent many years developing it explain it! Anyone that takes the time to read all the DD out could find it all out there. I'll be holding on to all my shares!! lol

https://www.otcdynamics.com/cyn-cyngn-publishes-white-paper-highlighting-the-case-for-autonomous-industrial-vehicles-in-the-future-of-manufacturing/

Agreed

ya its there I just rechecked might be 3rd party under research and ideas news

It is covered on TDA desk top

Lolol wtf lolol

Quarterly Report - OTC Disclosure Report for the Quarter Ending February 28, 202204/25/2022
https://www.otcmarkets.com/otcapi/company/financial-report/328709/content

Enzolytics, a Texas-based maker of monoclonal antibody drugs, has inked a deal with Samsung Biologics to support and manufacture its investigational new drug treatments for HIV and COVID-19.

The Yuan Community
@YuanCommunity
Erratum: #TheYuan incorrectly identified
@drgauravchandra
as #Enzolytics CEO in a previous tweet. He is in fact the firm's COO.
4:57 AM · Apr 2, 2022·Twitter Web App

Annual Report - Annual Disclosure Filing 12.31.202103/31/2022
https://www.otcmarkets.com/otcapi/company/financial-report/325767/content

Completely agree with this. If it were an enemy, they could have brought us even further down. Wonder how many shares they acquired? I do believe will see a very nice change in Volume as we get closer. #weregettingclose

Kumar Saggar that ENZC just added to advisory board?

Very excited to have Dr. Suraj Kumar Saggar join our Advisory Board of Enzolytics Inc.His appointment complements #enzc's growth as multiple products move towards clinical trials and patient use https://t.co/SY1bxviodv pic.twitter.com/bLWg45qBmz

— Gaurav Chandra M.D. (@drgauravchandra) February 28, 2022

lol they move it to ETRF Don't fall for it! Tennis anyone? lololol

lol look at that big Fake Wall of CDEL lol if anyone hit that ask watch how fast it disappears! nothing but games the funny part is it's the same game on so many OTC stocks for months now.

Lame

$ENZC ENZOLYTICS REPORTS ITS ENGAGEMENT OF SCENDEA USA, INC., A LEADING INTERNATIONAL PRODUCT DEVELOPMENT AND REGULATORY CONSULTING GROUP, TO GUIDE THE PROGRESS TOWARD CLINICAL TRIALS AND MARKET APPROVAL FOR ITS ITV-1 ANTI-HIV THERAPEUTIC
https://clinicdesign.eu/
www.scendea.com
Studies have shown it to be effective in treating HIV/AIDS. IPF is the active component of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has also been shown to modulate the immune system.

$ENZC Under the LOI, Creative would bear the cost of production and sale of the anti-HTLV-1 mAbs manufactured. From such sales, Creative would share with Enzolytics a percentage of net profit from sales of the anti-HTLV-1 mAbs made through Creative's channels of distribution. In the event Enzolytics chooses to commercialize the HTLV-1 mAbs, Enzolytics would share with Creative a percentage of the net profit or return generated from such sales.

$ENZC Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc. for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Announces-the-Signing-of-a-Letter-of-Intent-with-Creative-Biolabs-Inc-for-Licensing-and-Commercialization-of-?id=312286

$ENZC The Company is also implementing its proprietary technology to produce fully human monoclonal antibodies (mAbs) against infectious diseases, including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. Its proprietary methodology, covered in its pending U.S. Patent Application for producing fully human monoclonal antibodies, is currently employed to produce monoclonal antibody therapeutics for numerous infectious diseases, including the Coronavirus (SARS-CoV-2) and HTLV-1.

Enzolytics, Inc. Announces Production and Sale in North America of “Enzolytics IPF Immune(TM)”, A New Dietary Supplement That Enhances the Immune System
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Inc-Announces-Production-and-Sale-in-North-America-of-Enzolytics-IPF-ImmuneTM-A-New-Dietary-Supplement-That-E?id=337634

I hope your ready to drop some great news tomorrow morning Zack! Chart is ready your long term share holders are ready and the market looks bottomed. Time for some profits. LFG

Hoping so. Come on Zack lets get this party started!

O Boy it's happening! Enjoy the ride. Charts all looking real good!

On the bright side I don't own any Netflix lolol looks like reruns for the morning we can always hope they decide to flip the switch! GLTA I love my $ENZC shares!

$VNUE SS https://www.otcmarkets.com/stock/VNUE/security

$VNUE https://www.otcmarkets.com/stock/VNUE/news

https://www.otcmarkets.com/stock/VNUE/news/VNUE-SECURES-15MM-IN-EQUITY-FUNDING-FOR-STAGEIT-ACQUISITION?id=338074